Saturday, 22 April 2023
Program is in Lecture Room A (1st floor), LSU Medical Education Building
first Half
10am – 2pm
Central time zone (New Orleans)
| 10:00- | 10:10 | Welcome Remarks by Lihteh Wu MD |
| 10:10- | 10:15 | Nicolas Bazan MD PhD (USA) Introduction of the 1st Chancellor Award Lecture |
| 10:15- | 10:30 | Paulo E.C. Dantas MD PhD (Brazil) Chancellor Award Lecture: “Management of ocular cicatricial diseases of the eye: Past, present and future” |
| 10:30- | 10:35 | Q&A |
| 10:35- | 10:40 | Germán Bianchi MD (Argentina) Evaluation of vault in eyes with and without cysts after posterior chamber phakic lens implantation. |
| 10:40- | 10:45 | David Rodriguez MD (Mexico) Current state of scientific research of potential pterygium biomarkers: a bibliometric analysis |
| 10:45- | 10:50 | Marco Brugnera Master Degree in Pharmacy (Spain) One Single Eye Drop of Liposomes with Mucoadhesive Polymer Extends Hypotensive Effect of Latanoprost Compared to Marketed Formulation |
| 10:50- | 10:55 | Itamar Vigderovich (Mexico) Keratoconus stability after treatment with corneal cross-linking according to the Amsler-Krumeich classification |
| 10:55- | 11:00 | Alberto Castillo MD (Mexico) Ocular surface platelet-rich plasma membranes: setting preparation conditions |
| 11:00- | 11:05 | Jorge Domene Hickman MD (Mexico) Corneal biomechanical changes in a family carrying the TGFBI p.Ala546Asp pathogenic variant with granular corneal dystrophy type 2 phenotype |
| 11:05- | 11:10 | Daniela Fabregas-Sanchez-Woodworth MD (Mexico) Corneal Biomechanical Metrics by Corvis ST in a Healthy Mexican Population |
| 11:10- | 11:15 | |
| 11:15- | 11:20 | Naomi Zatarain Barrón MD (Mexico) Surgical Indications and Outcomes of Amniotic Membrane Transplantation in Ocular Surface Diseases |
| 11:20- | 11:25 | Luis Haro-Morlett MD (Mexico) Effect of Amniotic-membrane-derived lumican on cell migration and proliferation of human corneal epithelial cells |
| 11:25 | 11:30 | |
| 11:30- | 11:35 | Katiana Flores Nucamendi MD (Mexico) Antifibrotic activity of Siempreviva sap for potential pterygium treatment |
| 11:35- | 11:40 | Tatiana Suarez-Cortes PhD (Spain) The new once-daily multidose preservative-free 0.6% bilastine eye drop formulation containing sodium hyaluronate preserves ocular surface integrity and tear film homeostasis in a comparative in vivo study. |
| 11:40 | 11:45 | André Bando MD (Brazil) Correlation Between Risk of Fall and Glaucomatous Visual Field Defects |
| 11:45- | 11:50 | Nicolas Bazan MD PhD (USA) Introduction of the 2nd Chancellor Award Lecture |
| 11:50- | 12:05 | Fernando Arevalo MD PhD (USA) Chancellor Award Lecture: “Real World Data: What if Diabetic Retinopathy Patients are Lost to Follow-Up?” |
| 12:05- | 12:10 | Q&A |
| 12:10- | 12:15 | Francisco Javier Valentín Bravo MD, PhD student, FEBOphth (Spain) First-in-human simultaneous multiwavelength ultra-widefield (MW-UWF) fundus fluorescein (FFA) and indocyanine green (ICG) angiography with navigated central and peripheral swept-source optical coherence tomography (SS-OCT) imaging |
| 12:15- | 12:20 | Virginia Mares MD MSc (Brazil) AI-based retinal fluid monitoring correlated with automated photoreceptor loss quantification in neovascular AMD in the Fight Retinal Blindness! registry |
| 12:20- | 12:25 | |
| 12:25- | 12:30 | Emmanuel Issa Nassrallah BSc (Canada) Drusen quantification in post-mortem eyes implanted with or without blue-light filtering intraocular lenses |
| 12:30- | 12:35 | Victor Araujo BSc (Brazil) Double thermal cauterization of the limbal plexus as an inducible model of glaucoma in rats |
| 12:35- | 12:40 | Laura Prieto Domínguez MD (Spain) Virtual monitoring of macular function with artificial intelligence in diabetic patients. |
| 12:40- | 12:45 | Lia Huo BSc (Canada) Sustained Release of Sh3-RdCVF to Rescue Cone Photoreceptor Death |
| 12:45- | 12:50 | |
| 12:50- | 12:55 | Luis Nakayama MD (Brazil) Pixel Snow and Differential Privacy in Retinal fundus photos de-identification |
| 12:55- | 1:00 | Alaa Tayyib MD (Canada) Characterization of the Retinal Phenotype in PYGM-related McArdle Disease |
| 1:00- | 1:05 | Kavin Selvan BMSc (Canada) Validating Patient-Reported Outcome Measures for Adolescents with Inherited Retinal Diseases |
| 1:05- | 1:10 | Mohamed Abdouh PhD (Canada) Characterization of uveal melanoma-derived EV protein cargo for the determination of new therapeutic targets |
| 1:10- | 1:15 | Alicia Goyeneche PhD (Canada) Delineating three-dimensional behavior of uveal melanoma cells under anchorage independent or dependent methods |
| 1:15- | 1:20 | María Vaglienti (Argentina) PROTECTIVE EFFECT OF NITRO-OLEIC ACID ON OXIDATIVE STRESS, GLIOSIS AND PRO-ANGIOGENIC RESPONSE IN MÜLLER GLIAL CELLS |
| 1:20- | 1:25 | Thais Andrade MD (Brazil) Minimum rim width and peripapillary retinal nerve fiber layer in neuromyelitis optica spectrum disorders, glaucoma and healthy controls |
| 1:25- | 1:30 | Catalina Becerra-Revollo MD (Mexico) Doppler ultrasound features of intraocular tumors |
| 1:30- | 2:00 | Coffee Break |
Second Half
2 pm – 6pm
Central time zone (New Orleans)
| 2:00- | 2:05 | Rubens Belfort Jr. MD PhD (Brazil) Introduction of Keynote Lecture |
| 2:05- | 2:20 | Dr. Haydee Bazan PhD (USA) Keynote Lecture: “Novel RvD6 isomer promotes cornea nerve regeneration displaying a trigeminal transcriptome signature” |
| 2:20- | 2:25 | Q&A |
| 2:25- | 2:30 | |
| 2:30- | 2:35 | Guillermo Vera MD (Mexico) Refractive outcomes of posterior chamber phakic (Spheric and toric implantable Collamer lens) intraocular lens implantation with a central port design. |
| 2:35- | 2:40 | |
| 2:40- | 2:45 | Leyla Reyna Heredia MD (Mexico) Visual outcomes and complications in posterior lamellar transplants in a reference center |
| 2:45- | 2:50 | Rosa Alvarado-Villacorta MD (Spain) Allogeneic immunosafe plasma rich in growth factors as an alternative therapy in patients with refractory ocular surface disorders |
| 2:50- | 2:55 | Daniel Bastán-Fabián MD (Mexico) Facial Palsy and the Ocular Surface: Epidemiology, Tear Film, and Meibomian gland alteration analysis. |
| 2:55- | 3:00 | Afonso Lima-Cabrita MD (Portugal) AI in Hospital-Based Remote Glaucoma Screening: Outcomes in a Real World Setting |
| 3:00- | 3:05 | |
| 3:05- | 3:10 | Marcela Huertas-Bello MD (Colombia) Antimicrobial and anti-inflammatory effect of genipin in a rabbit model of Staphylococcus aureus and Pseudomonas aeruginosa keratitis |
| 3:10- | 3:15 | Luis Felipe Palomino De Anda MD (Mexico) Two-year outcomes in pediatric corneal crosslinking |
| 3:15- | 3:20 | Rossen Hazarbassanov MD PhD (Brazil) The suitability of color histogram-based features for keratoconus detection from corneal thickness with and neural networks. |
| 3:20- | 3:25 | Emely Marcotte BSc (Canada) Discovering the pathogenesis of cancer dissemination: The role of dual nature – hybrid cells in Uveal Melanoma |
| 3:25- | 3:30 | Gustavo Gameiro MD (Brazil) Hemifacial Spasm: gene expression and immunohistochemical analysis |
| 3:30- | 3:35 | William Rojas-Carabali MD (Colombia) Increased Risk for Dry Eye Disease in Children with Uveitis: A Case-Control Study |
| 3:35- | 3:40 | Nicolas Bazan MD PhD (USA) Introduction of the 3rd Chancellor Award Lecture |
| 3:40- | 3:55 | Rubens Belfort Jr. MD PhD (Brazil) Chancellor Award Lecture: “Implications of the COVID Eye Infection: Historic approach and the importance of the translational research” |
| 3:55- | 4:00 | Q&A |
| 4:00- | 4:05 | Alexia Vereertbrugghen (Argentina) A Th1-skewed immune response in the ocular surface favors corneal nerve damage |
| 4:05- | 4:10 | |
| 4:10- | 4:15 | Guillermo Salcedo-Villanueva MD (Mexico) Comparison of 10% and 25% Fluorescein for Oral Retinal Fluorescein Angiography |
| 4:15- | 4:20 | Julian Garcia-Sanchez MD (Mexico) Minimal Image Gain as an objective measurement for vitreous hemorrhages: Comparison of resolved versus persistent VH |
| 4:20- | 4:25 | Printha Wijesinghe BSc, MSc, PhD (Canada) Ergothioneine improves Aβ clearance in the neuroretina of a mouse model of Alzheimer’s disease (AD). |
| 4:25- | 4:30 | Melina del Papa PharmD (Argentina) Sodium hyaluronate improves corneal reinnervation and epithelial healing in an in vivo BAK-induced toxicity model |
| 4:30- | 4:35 | Juan Salvador Calanni MSc, PhD student (Argentina) EARLY LIFE STRESS DISTURBS RETINAL STRUCTURE AND VISUAL FUNCTION IN ADULT MICE THROUGH A GLUCOCORTICOID DEPENDENT MECHANISM |
| 4:35- | 4:40 | Salvador Pastor MD PhD (Spain) Tp53 Arg72Pro polymorphism is associated with the expression of apoptosis-related genes in the human retina after retinal detachment |
| 4:40- | 4:45 | Isabela Martins Melo MD (Canada) Bacillary Layer Detachment in the Pathophysiology of Macular Hole in Fovea-off Rhegmatogenous Retinal Detachment |
| 4:45- | 4:50 | Siddharth Nath MD PhD (Canada) Association of retinal bioparameters and periodontal disease: a cross-sectional analysis from the UK Biobank cohort |
| 4:50- | 4:55 | Mélanie Hébert MD MSc (Canada) Applying a new Classification of Ophthalmological Complications to the Protocol AB study |
| 4:55- | 5:00 | Adam Forman PhD (Canada) Injectable and Biodegradable Vitreous Substitute |
| 5:00- | 5:05 | Yosra Er-reguyeg Medical Student (Canada) Lamellar Macular Hole Surgery: Anatomical and Functional Outcomes |
| 5:05- | 5:10 | Eunice You MD MSc (Canada) Comparing treatments for chronic central serous chorioretinopathy: a systematic review with network meta-analyses |
| 5:10- | 5:15 | Bani Antonio-Aguirre MD MPH (USA) Effect of phakic status on residual peripheral visual islands in patients with retinitis pigmentosa |
| 5:15- | 5:20 | |
| 5:20- | 5:25 | Fernando Malerbi MD PhD (Brazil) Point-of-care Diabetic Retinopathy screening with a low-cost portable retinal camera, artificial intelligence and staged mydriasis in a rural, underserved area |
| 5:25- | 5:30 | Gulcenur Ozturan MD, FEBO, FICO (Canada) Training ophthalmologists on novel retinal characteristics uncovered using artificial intelligence |
| 5:30- | 5:35 | Rubens Belfort Jr. MD PhD Introduction of Keynote Speaker |
| 5:35- | 5:50 | Nicolas Bazan, MD PhD (USA) Keynote Lecture: “Rod-specific downregulation of omega-3 very-long chain polyunsaturated fatty acid pathway in age-related macular degeneration” |
| 5:50- | 6:00 | Program ends, Final Comments and Awards Presentation |
| 6:00 | Reception (for registered attendees only) |